Back to the complete issue
Sunday, 27 November 2022

Crypto winter hasn’t spilled over into the traditional financial sector + Mini robots to administer drugs and treat disease?

Why the collapse of crypto hasn’t really tainted the world’s economy: Crypto, which was once valued at around USD 3 tn, has lost 72% of its value y-o-y, with little to no impact on the traditional financial sector, according to Wall Street Journal’s chief economics commentator Greg Ip. Because the asset class isn’t linked to the rest of the financial world, its issues haven’t spilled over. Things could have turned out differently if the crash were to take place in a couple of years, given the increasing pressure on regulators and banks to accept crypto into the traditional financial world.

The crypto space is “largely circular,” meaning when crypto platforms get money from their investors, they use the funds to trade and finance themselves. They barely interact with businesses that benefit the real economy, according to economists. Unlike government bonds, mortgages, commercial loans, and even derivatives, cryptocurrency had no practical application and thus provided little incentive for traditional finance to connect to it. Because of its lack of regulation and overall volatile nature, regulators and institutional investors were already wary of crypto, while mainstream investors such as Warren Buffett avoided it entirely. This would have changed over time, but not because crypto became useful, writes Ip. It would have changed due to the amount of money it generated for speculators and the ecosystem that supported them.


From Face ID to drug-administering mini robots: The US’ Bionaut Labs has employed the team behind Apple’s Face ID to develop remote-controlled small robots to deliver meds into the brain to target difficult-to-treat diseases, the Financial Times reports. The company secured USD 43.2 mn in a second funding round, led by Khosla Ventures, to finance the first clinical trials to prove the robots' safety and effectiveness. Israel’s Deep Insight and Canada’s Sixty Degree Capital, were among the seven new investors that joined the round. Bionaut Labs is beginning trials to administer drugs to treat a form of brain tumor and Dandy-Walker Syndrome, a rare pediatric neurological illness, in which the robot will poke a hole in a cyst. Biopsies taken by the robots could also be used to diagnose diseases. The company ultimately wants to tackle more difficult and common diseases including Parkinson’s, Huntington's, Alzheimer's, and strokes.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; and Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt.